Investigation of cancer incidence and mortality at a Scottish semiconductor manufacturing facility
|
|
- Jeremy Carr
- 6 years ago
- Views:
Transcription
1 Occupational Medicine 2003;53: DOI: /occmed/kqg111 Investigation of cancer incidence and mortality at a Scottish semiconductor manufacturing facility Damien M. McElvenny 1, Andrew J. Darnton 1, John T. Hodgson 1, Simon D. Clarke 1, Richard C. Elliott 2 and John Osman 1 Background We became aware of concern about cancer at a Scottish semiconductor manufacturing facility in Aim Method Results Conclusion Key words To compare cancer experience among current and former workers at the facility, with an appropriate comparison population, making use of any readily available exposure information. We obtained personnel and employment episode information from four sources within the company. Workers were flagged for death and cancer registrations at the National Health Service Central Register in Edinburgh. We constructed standardized registration and mortality ratios (SRRs and SMRs), using Scotland as the comparison, with and without an adjustment for deprivation. The main mortality analysis included 4388 workers, with a mean length of follow-up of 12.5 years. Overall mortality was substantially below that expected for men, and for women was slightly below expected. Total cancer registrations were close to expected levels for men and women. Four cancers produced noteworthy findings: malignant neoplasm of the trachea, bronchus and lung in women deprivation adjusted SRR [95% confidence interval (CI), number of cases] 273 ( , 11 cases); malignant neoplasm of the stomach in women adjusted SRR 438 ( , three cases); and malignant neoplasm of the female breast adjusted SRR 134 (82 206, 20 cases). The unadjusted SMR for male brain cancer was 401 ( , three cases) and there was an additional non-fatal case. These findings, particularly those relating to lung cancer, though inconclusive, point to the possibility of a work-related risk of cancer that justifies further investigation. Cancer; occupation; semiconductor. Received 17 December 2002 Revised 27 May 2003 Accepted 7 July 2003 Introduction Concern that there might be a cluster of cancers in the British semiconductor industry first came to our attention in late The concern was almost 1 Epidemiology and Medical Statistics Unit, Health & Safety Executive, Bootle, Merseyside, UK. 2 Medical Unit, Health & Safety Executive, Bootle, Merseyside, UK. Correspondence to: Dr John Osman, Epidemiology and Medical Statistics Unit, Health & Safety Executive, Room 236 Magdalen House, Stanley Precinct, Bootle, Merseyside L20 3QZ, UK. john.osman@hse.gsi.gov.uk exclusively centred on a single semiconductor manufacturing facility in Scotland, and was expressed in the form of workers support group actions, media coverage, and parliamentary activity. We identified only two epidemiological studies specific to cancer risk in semiconductor manufacturing, both conducted on the same cohort of workers at a semiconductor factory in the West Midlands region of England [1,2]. The initial investigation [1] provided evidence of a cluster of melanoma in women, which disappeared with further follow-up [2]. D. M. McElvenny, Health & Safety Executive. Crown Copyright Reproduced with the permission of the Controller of Her Majesty s Stationery Office. 419
2 420 OCCUPATIONAL MEDICINE The aims of this investigation were limited to establishing the level of cancer incidence and mortality in the workforce compared with an appropriate reference population and relating this incidence to any readily available information on individuals histories of work in the plant. The intention was to establish some basic facts relatively quickly to replace the existing anecdotal information, and decide whether more extensive investigation would be justified. The data collection was therefore approached in such a way that it would form a sound basis for further more detailed investigation, should that prove necessary. Methods A protocol was prepared for the investigation, and this was endorsed by an independent steering committee with expertise in statistics and epidemiology, and occupational and public health medicine. We compiled a list of known or suspected carcinogenic substances or agents that had been present or in use at the factory since the start of operations in 1970 (Table 1). We also utilized a list of cancers that were present on the (now defunct) worker support group s website ( williamson/home.htm). These information sources enabled the inclusion of a focused set of disease groups in the study. In addition we looked at broad cancer groups and mortality from certain causes to help interpret the findings. An initial data set was compiled that consisted of surname, maiden name, forenames, sex, date of birth, National Insurance number, current or last known address and employment episodes. The data set included all men and women who were employed by the company at the facility on or before 30 April The data were checked for missing information and validated for Table 1. Known or suspected carcinogens present or in use at the factory Antimony trioxide Arsenic and arsenical compounds Arsine Asbestos (in buildings) Chromium trioxide Kaowool Highly refined mineral oil Arsine/arsenical compound contaminated oil Sulphuric acid mists Ionizing radiaton UV radiation Krypton 85 Carbon tetrachloride Chromic acid Trichloroethane Trichloroethylene internal consistency. Missing or inconsistent data items and potential duplicate records were queried with the company, and data amendments were made on the basis of their response. The completeness and accuracy of the personnel data on the master computer file were assessed by crosschecking with a sample of records from the original sources within the company (personnel, pension, payroll and occupational health). Initially, the aim was to sample ~10% of the source records in this way. However, the sample was extended to 100% for pension and payroll records after identifying a number of individuals from these sources missing from the master file. Altogether, an additional 425 workers were identified and added to the master file. These could not be confirmed as UK nationals having worked for the company at the facility and were thus marked as unconfirmed workers. Where possible, inaccuracies in the data identified by the checking process were corrected. The master file was sent to the National Health Service Central Register (NHSCR) maintained by the General Register Officer for Scotland [GRO(S)] for tracing and notification of deaths and cancer registrations. Details of any workers initially untraced on the NHSCR were sent to the Department for Work and Pensions in Newcastle upon Tyne to enable the worker s National Insurance number to be used to identify fact and date of death information where applicable, or for confirming or correcting personnel information. Any records where new information was obtained via this method were then retraced at the NHSCR. In order to check that cancer registration data supplied by GRO(S) were complete, the data file was sent to the Scottish Health Service s Information and Statistics Division (ISD) and traced against the Scottish Cancer Registration Database. Any workers flagged as unconfirmed workers, after carrying out the check of completeness and accuracy of the personnel data, were excluded from the analysis data file. Although we did not attempt to collect detailed information on exposures at the individual level, since it was beyond the scope of this investigation, we nevertheless looked for a means to possibly distinguish different exposure subgroups within the study population. The only readily available source of data that could practically be used was assignment to work area as recorded by the occupational health department. Initially, this assignment was based on pre-employment medical check, but was updated opportunistically as workers came into contact with the company s occupational health department. The work areas were classified for analysis as fabrication (fab the areas in which the semiconductor chips are manufactured) or nonfabrication (non-fab). The dates when workers changed
3 D. M. MCELVENNY ET AL.: CANCER INCIDENCE, MORTALITY AND SEMICONDUCTOR MANUFACTURING 421 from working in fab to non-fab or vice versa were not usually available. Thus, workers were categorized as ever having worked in fab or not. These data were extracted by the study team and validated. For the mortality analysis, the end of follow-up was 31 December 2000, and for the cancer registration analysis it was 31 December At the time of the analysis, Scottish cancer registration data for 1998 from ISD were 96% complete and England and Wales data were 99% complete. Event data supplied by GRO(S) were coded to ICD8 [3] to 1978 and ICD9 [4] for 1979 onwards. Data supplied by ISD were coded to ICD10 [5]. All data were recoded by a member of the study team to ICD9 before analysis. The choice of the population on which to base the expected mortality or cancer incidence was a compromise between using national and local data. Local rates would best reflect the general health profile of the local population but were considered too unstable. Therefore our adjusted rates were Scottish rates but with an adjustment (different for males and females) based on the Carstairs index of deprivation [6], which was intended to take into account average health profile of the economically deprived area of Scotland in which the plant was based. The unadjusted rates were based on Scottish rates without the adjustment for deprivation. Because we did not have appropriate address information for all former employees, we could not stratify at the individual level, but rather chose to re-weight the Scottish deprivation specific rates in the standardized registration and mortality ratios (SRRs and SMRs) according to the geographical distribution of residence of current employees. The software used to calculate the SMRs and SRRs was OCMAP-PLUS v3.09 (Beta v1.0) [7], and all data manipulations and calculations were carried out using SPSS [8]. A single 10 year cut-off point was used for latency (time since first employment) analyses, since the relatively short average length of follow-up prohibited use of a longer one (e.g. 15 year cut-off point or >2 latency analysis categories). Analyses by date of start were run using two groups divided at 1982, the year which gave approximately equal expected numbers of registrations for all cancers in the two date of start subgroups. Similarly, analyses by age were divided at age 50, the five-year point giving approximately equal numbers of expected all malignant neoplasms in the two age subgroups. Appropriate ethical clearances were obtained for the investigation, and the data for the study were registered in accordance with current UK data protection legislation. As with all retrospective cohort studies, it was not practicable to seek the explicit consent of every individual included in the investigation. However, the study proposals were presented to all current workers, and current and former workers were sent a leaflet explaining the investigation and offering the opportunity to opt out of the investigation. We undertook to ensure that the management and workforce at the facility would hear the results of this investigation before they were made public, and our main means of doing this was to produce a results leaflet mailed to each current and former worker. In addition, we undertook to give presentations to all shifts of workers the same day as, or shortly after, receipt of the leaflet. We also undertook to provide a confidential freephone telephone line to deal with any concerns that individuals may have had about the findings of the investigation. Results Vital status Details of 4547 employees who were confirmed as working at the facility and who were not identified as non-uk nationals were submitted for tracing at the NHSCR, 159 (3.5%) of whom were untraced (64 males; 95 females). Of the remaining 4388 workers who were traced (2126 males, 2262 females), 4067 (93%) were traced in Scotland, 318 (7%) in England and Wales, and three (<1%) in Northern Ireland. The distribution of the vital status of the 4388 traced workers at the end of 2000, who were included in the mortality analyses is set out in Table 2. Twenty-seven (1.3%) out of 2126 male workers and 44 (1.9%) out of 2262 female workers had died. Eleven (<1%) males and seven (<1%) females had emigrated. Five workers were excluded from the cancer registration analyses due to their start of employment being after the cut-off for the cancer registration analysis (31 December 1998), or their being traced in Northern Ireland, for where cancer registration data were not available. After exclusion of cancer registrations that occurred prior to start of employment, or after the cut-off date for the analysis, there were 125 cohort members that had cancer registrations included in the analysis. Of these, two were associated with more than one primary cancer registration. Table 2. Vital status of traced workers at 31 December 2000 Male (%) Female (%) Total (%) Alive current worker 659 (31) 649 (29) 1308 (30) Alive former worker 1429 (67) 1562 (69) 2991 (68) Dead 27 (1) 44 (2) 71 (2) Emigrated from UK 11 (1) 7 (0) 18 (0) Total 2126 (100) 2262 (100) 4388 (100)
4 422 OCCUPATIONAL MEDICINE Descriptive statistics Two thousand, one hundred and fifty-two (49%) workers were aged under 25 years at hire, and 3688 (84%) were aged under 35 years at hire. There is some evidence that women on average tend to be slightly younger than men when hired. The overall mean length of follow-up for the mortality analysis was 12.5 years. Around 20% of men and women had <12 months employment, 37% of men had >1 and <5 years service, and the equivalent percentage for women was 33%. Twenty per cent of men had >10 years service, as did 25% of women. Thus, females tended to work slightly longer at the factory than males. From the company s occupational health records, 1081 out of 2126 (51%) males were recorded as working in fab areas whereas 1793 out of 2262 females (79%) were recorded as working in fab areas. The number of workers employed at the facility increased steadily from the mid-1970s to 1995, passing 500 in 1981 and 1000 in 1984, and reaching ~2000 in The number had decreased steadily from a peak of over 2000 in 1995 to ~1250 by April Mortality analyses The male mortality results by disease groups are presented in Table 3 and the equivalent results for females are presented in Table 4. There was a statistically significant deficit in male mortality, adjusted SMR = 40 [95% confidence interval (CI) = 27 59, 27 cases] (Table 3), providing evidence of a strong healthy worker effect in men, which persists when the analysis is restricted to a latency of 10 years. There was also a slight deficit of female mortality, adjusted SMR = 75 (95% CI = , 44 cases) (Table 4), thus providing weak evidence of a healthy worker effect in women. Due to the overlap between the mortality and cancer registration results, most of the results will concentrate on the cancer registration analyses. One mortality finding among men was noteworthy, however: the unadjusted SMR for three fatal brain cancers (a disease group not of specific interest at the outset of the investigation) was 401 (95% CI = ), and there was an additional non-fatal case. Three cases had a latency of <10 years with ages at diagnosis of 23, 35 and 56 years respectively. The non-fatal case was aged 32 years at diagnosis. Cancer registration analyses The male cancer registration results by disease groups are presented in Table 5 and the equivalent results for females are presented in Table 6. The adjusted SRR for all malignant neoplasms for males was 99 (95% CI = , 25 cases) (Table 5) and for females was 111 (95% CI = , 54 cases) (Table 6). A statistically significant excess of lung cancer and an excess of stomach cancer in women, which was of borderline statistical significance, were identified. There was also a nonsignificant excess of breast cancer [where there was an absolute excess of around five cases (34%, adjusted) above that expected]. Of the 11 female lung cancers, five had a latency of <10 years, with ages at diagnosis ranging from 46 to 55 years. Five female cases had a latency of years with a range of ages at diagnosis of years. One woman had a latency of >20 years and was aged 60 years at diagnosis. One of the female lung cancers was non-fatal. Note that one of the two male lung cancers was non-fatal, the other case died from myocardial infarction. Detailed lung cancer registration results for female lung cancers are set out in Table 7. There are three to four times as many lung cancer registrations as expected among women who have worked at the factory. This excess is reduced slightly, but persists after an adjustment is made for deprivation. The excess also remains, again with a slight reduction, after exclusion of workers employed for <12 months. The excess is more pronounced for a latency of <10 years than for 10 years. The excess is similar in observations on women aged 50 years compared with women aged under 50 years. The excess is more pronounced in women first employed in 1982 or later than those first employed before The excess seems marginally higher in women who work in fab areas. None of these internal contrasts was statistically significant. The cell types of the female lung cancers had the following distribution: adenocarcinoma not otherwise specified (NOS) (four); small cell carcinoma NOS (two); carcinoma NOS (two); squamous cell carcinoma NOS (one); large cell carcinoma (one); and oat cell carcinoma (one). The three women with stomach cancer were diagnosed between 5 and 10 years after (first) starting work at the factory, and all were aged <45 years at diagnosis. Two of the cancers were fatal. Detailed female stomach cancer results are set out in Table 8. There are four to five times more stomach cancers than expected. The excess was reduced slightly but persisted after adjustment for deprivation. The excess was increased slightly after exclusion of workers employed for <12 months. The excess was restricted to a latency of <10 years and observations on women aged <50. The excess was similar for women first employed before 1982 compared with those first employed after 1982 and also for those working in the fab compared with other women. These informal comparisons should be interpreted cautiously because of the small number of cases involved, and none was statistically significant. Four of the 20 breast cancers cases had died by the end of Ten of the cases had a latency of <10 years, with ages at diagnosis ranging from 31 to 60 years. For the eight cases with a latency between 10 and 20 years, the ages at diagnosis ranged from 35 to 57 years. For the two cases with latency of over 20 years, both were aged over
5 D. M. MCELVENNY ET AL.: CANCER INCIDENCE, MORTALITY AND SEMICONDUCTOR MANUFACTURING 423 Table 3. Male mortality by disease group to 2000: numbers of deaths and SMRs with and without Carstairs adjustment Disease group (ICD9) Total No. of cases Unadjusted SMR Adjusted a SMR All causes ( ) 27 46** (30 67) 40** (27 59) All malignant neoplasms ( ) 6 51 (19 111) 47 (17 102) Malignant neoplasms of the lip, oral cavity and pharynx ( ) 0 0 (0 880) 0 (0 682) Malignant neoplasms of the digestive organs and peritoneum ( ) 2 60 (7 218) 57 (7 205) Malignant neoplasms of the stomach (151) 0 0 (0 608) 0 (0 550) Malignant neoplasms of respiratory and intrathoracic organs ( ) 0 0 (0 106) 0* (0 90) Malignant neoplasm of the trachea, bronchus and lung (162) 0 0 (0 114) 0* (0 97) Malignant neoplasms of the pleura (163) 0 0 (0 4622) 0 (0 4464) Malignant neoplasms of the genitourinary organs ( ) 0 0 (0 333) 0 (0 327) Malignant melanomas of the skin (172) 0 0 (0 1384) 0 (0 1488) Other malignant neoplasms of the skin (172) 0 0 (0 9862) 0 (0 8039) Malignant neoplasm of the thyroid gland (193) 0 0 ( ) 0 ( ) Malignant neoplasms of the lymphatic and haematopoietic tissue ( ) 1 81 (2 453) 82 (2 459) Multiple myeloma (203) 0 0 (0 3576) 0 (0 3756) Leukaemia ( ) 0 0 (0 824) 0 (0 812) Leukaemia excluding chronic lymphatic leukaemia (204.0, ) 0 0 (0 919) 0 (0 900) Benign neoplasms ( ) 0 0 (0 8474) 0 (0 8797) Neoplasms of uncertain behaviour or unspecified nature ( ) 0 0 ( (0 3722) Diseases of the blood and blood-forming organs ( ) 0 0 (0 3159) 0 (0 2828) Diseases of the circulatory system ( ) (30 114) 55 (26 101) Diseases of the respiratory system ( ) 1 35 (1 196) 29 (1 160) Diseases of the genitourinary system ( ) 0 0 (0 1248) 0 (0 1116) **Statistically significant at the 2-sided 1% level of significance. *Statistically significant at the 2-sided 5% level of significance. Table 4. Female mortality by disease group to 2000: numbers of deaths and SMRs with and without Carstairs adjustment Disease group (ICD9) Total No. of cases Unadjusted SMR Adjusted a SMR All causes ( ) (67 123) 75 (54 101) All malignant neoplasms ( ) (76 180) 110 (69 164) Malignant neoplasms of the lip, oral cavity and pharynx ( ) 0 0 (0 1722) 0 (0 1677) Malignant neoplasms of the digestive organs and peritoneum ( ) 3 92 (19 268) 88 (18 256) Malignant neoplasms of the stomach (151) ( ) 327 ( ) Malignant neoplasms of respiratory and intrathoracic organs ( ) ** ( ) 231* ( ) Malignant neoplasm of the trachea, bronchus and lung (162) ** ( ) 241* ( ) Malignant neoplasms of the pleura (163) 0 0 ( ) 0 ( ) Malignant neoplasms of the genitourinary organs ( ) 2 60 (7 218) 54 (7 196) Malignant neoplasms of the uterus (179, 182) 0 0 (0 1659) 0 (0 1686) Malignant melanomas of the skin (172) (8 1696) 354 (9 1973) Other malignant neoplasms of the skin (173) 0 0 ( ) 0 ( ) Malignant neoplasms of the female breast (174) 4 74 (20 191) 74 (20 190) Malignant neoplasm of the thyroid gland (193) 0 0 ( ) 0 (0 8981) Malignant neoplasms of the lymphatic and haematopoietic tissue ( ) (18 543) 140 (17 506) Multiple myeloma (203) 0 0 (0 2647) 0 (0 2345) Leukaemia ( ) (5 1109) 172 (4 961) Leukaemia excluding chronic lymphatic leukaemia (204.0, ) (5 1156) 180 (5 1005) Benign neoplasms ( ) 0 0 (0 6390) 0 (0 5312) Neoplasms of uncertain behaviour or unspecified nature ( ) 0 0 (0 3211) 0 (0 3042) Diseases of the blood and blood-forming organs ( ) 0 0 (0 2652) 0 (0 2325) Diseases of the circulatory system ( ) 5 46 (15 108) 35** (11 81) Diseases of the respiratory system ( ) (36 337) 94 (26 241) Diseases of the genitourinary system ( ) (6 1321) 182 (5 1012) **Statistically significant at the 2-sided 1% level of significance. *Statistically significant at the 2-sided 5% level of significance.
6 424 OCCUPATIONAL MEDICINE Table 5. Male cancer registrations by disease group to 1998: numbers of cancer registrations and SRRs with and without Carstairs adjustment Disease group (ICD9) Total No. of cases Unadjusted SRR Adjusted a SRR All malignant neoplasms ( ) (67 153) 99 (64 147) Malignant neoplasms of the lip, oral cavity and pharynx ( ) 0 0 (0 410) 0 (0 344) Malignant neoplasms of the digestive organs and peritoneum ( ) 3 72 (15 211) 68 (14 198) Malignant neoplasms of the stomach (151) 0 0 (0 479) 0 (0 441) Malignant neoplasms of respiratory and intrathoracic organs ( ) 3 83 (17 243) 71 (15 207) Malignant neoplasm of the trachea, bronchus and lung (162) 2 66 (8 238) 56 (7 202) Malignant neoplasms of the pleura (163) 0 0 (0 2666) 0 (0 2342) Malignant neoplasms of the genitourinary organs ( ) 5 99 (32 231) 97 (31 225) Malignant melanomas of the skin (172) (20 595) 186 (23 671) Other malignant neoplasms of the skin (173) (27 256) 104 (28 265) Malignant neoplasm of the thyroid gland (193) 0 0 (0 2003) 0 (0 2255) Malignant neoplasms of the lymphatic and haematopoietic tissue ( ) (22 305) 106 (22 308) Multiple myeloma (203) 0 0 (0 2334) 0 (0 2401) Leukaemia ( ) 0 0 (0 550) 0 (0 543) Leukaemia excluding chronic lymphatic leukaemia (204.0, ) 0 0 (0 697) 0 (0 683) Carcinomas in situ ( ) 0 0 (0 672) 0 (0 724) Table 6. Female cancer registrations by disease group to 1998: numbers of cancer registrations and SRRs with and without Carstairs adjustment Disease group (ICD9) Total No. of cases Unadjusted SRR Adjusted a SRR All malignant neoplasms ( ) (84 145) 111 (83 145) Malignant neoplasms of the lip, oral cavity and pharynx ( ) (4 890) 143 (4 799) Malignant neoplasms of the digestive organs and peritoneum ( ) 4 88 (24 225) 86 (23 220) Malignant neoplasms of the stomach (151) 3 491* ( ) 438 ( ) Malignant neoplasms of respiratory and intrathoracic organs ( ) ** ( ) 245* ( ) Malignant neoplasm of the trachea, bronchus and lung (162) ** ( ) 273** ( ) Malignant neoplasms of the pleura (163) 0 0 ( ) 0 (0 6809) Malignant neoplasms of the genitourinary organs ( ) 7 72 (29 149) 66 (27 136) Malignant neoplasms of the uterus (179, 182) 1 76 (2 426) 74 (2 410) Malignant melanomas of the skin (172) 2 70 (9 253) 88 (11 319) Other malignant neoplasms of the skin (173) (40 235) 125 (46 272) Malignant neoplasms of the female breast (174) (76 193) 134 (82 206) Malignant neoplasm of the thyroid gland (193) 0 0 (0 447) 0 (0 577) Malignant neoplasms of the lymphatic and haematopoietic tissue ( ) (22 314) 110 (23 322) Multiple myeloma (203) 0 0 (0 1872) 0 (0 1795) Leukaemia ( ) (4 776) 145 (4 806) Leukaemia excluding chronic lymphatic leukaemia (204.0, ) (4 899) 167 (4 933) Carcinomas in situ ( ) (63 114) 94 (69 125) **Statistically significant at the 2-sided 1% level of significance. *Statistically significant at the 2-sided 5% level of significance. 50 years at diagnosis. Detailed female breast cancer results are set out in Table 9. Although the breast cancer result was not as striking as those for lung and stomach cancers, it represents an ~30% excess of observed over expected cases, and was based on 20 cases. The excess was increased slightly when an adjustment was made for deprivation. However, the excess was substantially reduced when the analysis was restricted to women employed for 12 months. The excess was slightly higher for latency <10 years compared with a latency of 10 years. The excess was higher for observations on women aged 50 years than for those aged <50 years. The excess was markedly higher for those women first employed in 1982 or later compared with those first employed before Within those women first employed after 1982, there seems little difference between the analysis based on
7 D. M. MCELVENNY ET AL.: CANCER INCIDENCE, MORTALITY AND SEMICONDUCTOR MANUFACTURING 425 Table 7. Female lung cancer (ICD9 162) registrations to 1998: numbers and SRRs by latency for selected subgroups Analysis type Total Latency < 10 years Latency 10 years Total females Unadjusted SRR 373** ( ) 544** ( ) 296* ( ) No. of cases Adjusted a SRR 273** ( ) 390* ( ) 218 (80 475) Females employed for <12 months excluded Unadjusted SRR 325** ( ) 381 ( ) 302* ( ) No. of cases Adjusted SRR 238* ( ) 273 (56 798) 223 (82 485) Females aged <50 years Unadjusted SRR 370* ( ) 500* ( ) 207 (5 1154) No. of cases Adjusted SRR 262 (71 671) 355 ( ) 146 (4 816) Females aged 50 years Unadjusted SRR 376** ( ) 627 ( ) 324* ( ) No. of cases Adjusted SRR 279 *( ) 458 ( ) 242 (79 564) Females first employed before 1982 Unadjusted SRR 299* ( ) 0 (0 963) 369* ( ) No. of cases Adjusted SRR 220 (81 479) 0 (0 688) 274* ( ) Females first employed 1982 or later Unadjusted SRR 533** ( ) 933** ( ) 0 (0 918) No. of cases Adjusted SRR 383* ( ) 671** ( ) 0 (0 658) Females working in fab areas Unadjusted SRR 436** ( ) 743** ( ) 287 (78 735) No. of cases Adjusted SRR 317** ( ) 532** ( ) 211 (57 540) Females working in non-fab areas Unadjusted SRR 227 (28 821) 0 (0 1502) 315 ( ) No. of cases Adjusted SRR 167 (20 605) 0 (0 1080) 235 (28 847) **Statistically significant at the 2-sided 1% level of significance. *Statistically significant at the 2-sided 5% level of significance. latency <10 years compared with that based on a latency of 10 years. There was a non-significant excess in women recorded as working in fab areas, and a non-significant deficit for women recorded as working outside the fab. For women, apart from the cancers discussed in the previous paragraphs, there were no findings of note. For men, none of the cancer groupings selected for analysis produced statistically significant results. The highest SRR in men was produced by two cases of malignant melanoma, nearly twice the expected level (on an adjusted basis), but not statistically significant. Our approach It had been argued from the outset that the study should have looked at a wider range of health outcomes and encompassed the whole of the industry in Great Britain [9,10]. In reply, we argued that the pre-existing evidence for concern did not justify the commitment of resources implied by such a study [11, a further response was not published]. We believe that despite its moderate size and these limited aims, the present study represents a substantial addition to the available evidence on cancer risks in the semiconductor manufacturing industry. Discussion To our knowledge, this is only the second formal study of cancer in a semiconductor plant. Its aim was limited to establishing cancer incidence in the workforce population and to assess the need for further investigation. Completeness and accuracy of data Considerable efforts were made to ensure that the cohort was as complete as possible. Of the 425 workers who could not be confirmed as UK employees who worked at the factory, only 36% were traced at the NHSCR. This low trace rate is consistent with most of them being
8 426 OCCUPATIONAL MEDICINE Table 8. Female stomach cancer (ICD9 151) registrations to 1998: numbers and SRRs by latency for selected subgroups Analysis type Total Latency < 10 years Latency 10 years Total females Unadjusted SRR 491* ( ) 1213**( ) 0 (0 1015) No. of cases Adjusted a SRR 438 ( ) 1093**( ) 0 (0 900) Females employed for <12 months excluded Unadjusted SRR 528* ( ) 1402**( ) 0 (0 1041) No. of cases Adjusted SRR 469 ( ) 1251**( ) 0 (0 923) Females aged <50 years Unadjusted SRR 957** ( ) 1560**( ) 0 (0 3043) No. of cases Adjusted SRR 884* ( ) 1416**( ) 0 (0 2889) Females aged 50 years Unadjusted SRR 0 (0 1241) 0 (0 6698) 0 (0 1523) No. of cases Adjusted SRR 0 (0 1070) 0 (0 5879) 0 (0 1308) Females first employed before 1982 Unadjusted SRR 532 ( ) 2009**( ) 0 (0 1334) No. of cases Adjusted SRR 459 ( ) 1671* ( ) 0 (0 1166) Females first employed 1982 or later Unadjusted SRR 426 ( ) 677 ( ) 0 (0 4246) No. of cases Adjusted SRR 403 ( ) 646 ( ) 0 (0 3949) Females working in fab areas Unadjusted SRR 457 ( ) 1076* ( ) 0 (0 1462) No. of cases Adjusted SRR 410 ( ) 977* ( ) 0 (0 1305) Females working in non-fab areas Unadjusted SRR 579 ( ) 1626 ( ) 0 (0 3317) No. of cases Adjusted SRR 508 ( ) 1431 ( ) 0 (0 2901) **Statistically significant at the 2-sided 1% level of significance. *Statistically significant at the 2-sided 5% level of significance. non-uk nationals, and it was thus appropriate to exclude them from our analysis. (It was known that a number of non-uk nationals worked at the plant in its early years of operation.) Further, it was not judged appropriate to include them via a sensitivity analysis. In contrast, 96.5% of the confirmed workers were traced at the NHSCR. Staff at the factory had the option of utilizing private health care. We were advised that this would be unlikely to affect completeness of cancer registration in the cohort (C. R. Gillis and D. J. Hole, personal communications). There are doubts about the completeness of cancer registration in the local area compared with the rest of Scotland in the early years of operation of the factory (C. R. Gillis and D. J. Hole, personal communications). However, most of the cancers in this workforce would be expected after the 1970s and, although a potential problem, this was unlikely to mask any excesses that would otherwise have been found. At the time of the analyses cancer registrations in England and Wales were complete to the end of 1998 (M. Quinn, personal communication). Cohort size and follow-up The investigation cohort is limited in size, and since the factory only began operations in 1970 and did not recruit large numbers until the early 1980s, the average length of follow-up of 12.5 years is relatively short for a statistical analysis of the type undertaken here. However, the limitations of cohort size and follow-up were unavoidable in the context of this investigation. Also, at the outset of this investigation, there was insufficient justification for an industry-wide study to be conducted, and the study reported here was designed so that data could be pooled with any data from such a future study. Thus an urgent assessment was required of the evidence for or against
9 D. M. MCELVENNY ET AL.: CANCER INCIDENCE, MORTALITY AND SEMICONDUCTOR MANUFACTURING 427 Table 9. Female breast cancer (ICD9 174) registrations to 1998: numbers and SRRs by latency for selected subgroups Analysis type Total Latency < 10 years Latency 10 years Total females Unadjusted SRR 125 (76 193) 137 (65 251) 116 (55 212) No. of cases Adjusted a SRR 134 (82 206) 145 (70 267) 124 (59 228) Females employed for <12 months excluded Unadjusted SRR 109 (63 178) 96 (35 210) 119 (57 219) No. of cases Adjusted SRR 117 (67 190) 102 (38 223) 128 (61 235) Females aged <50 years Unadjusted SRR 93 (45 171) 112 (45 230) 67 (14 196) No. of cases Adjusted SRR 99 (48 182) 118 (48 244) 72 (15 210) Females aged 50 years Unadjusted SRR 191 (92 351) 286 (59 836) 167 (67 344) No. of cases Adjusted SRR 204 (98 375) 304 (63 888) 179 (72 368) Females first employed before 1982 Unadjusted SRR 61 (20 143) 43 (1 239) 68 (19 175) No. of cases Adjusted SRR 65 (21 152) 45 (1 251) 73 (20 188) Females first employed 1982 or later Unadjusted SRR 192* ( ) 180 (82 342) 213 (78 465) No. of cases Adjusted SRR 206* ( ) 192 (88 365) 229 (84 498) Females working in fab areas Unadjusted SRR 141 (82 226) 139 (60 275) 142 (65 270) No. of cases Adjusted SRR 150 (88 241) 148 (64 292) 153 (70 289) Females working in non-fab areas Unadjusted SRR 77 (16 224) 126 (15 455) 43 (1 239) No. of cases Adjusted SRR 82 (17 238) 134 (16 482) 46 (1 256) **Statistically significant at the 2-sided 1% level of significance. *Statistically significant at the 2-sided 5% level of significance. the claim of excess cancer incidence in this workforce. This assessment would then inform consideration of the need for further more detailed and industry-wide investigations. Adjustment for deprivation The expected numbers in the present analyses have been calculated on two different bases. First, simply using national Scottish rates, and secondly using rates based on the national Scottish data but adjusted to reflect the socio-economic profile of the local area (strictly, the areas of residence of current employees). A priori, the adjusted data should provide a better basis for assessing the presence of workplace risks, though any evidence of risk has to be interpreted with the possibility of further distortion from the healthy worker effect. Also there remains a possible issue in relation to how appropriate the adjustments made in this investigation are, since it is not clear whether the background rate of cancer in this workforce should be thought of as being the same as in the local population, due to the potential influence from influx of workers not indigenous to the area. Furthermore, the extent of this could be different for men and women. In any case the adjustment for deprivation does not materially change our conclusions. Overall mortality experience Mortality from all causes was substantially less than expected for men and slightly below expected levels for women. The pattern of these deficits by latency is consistent with a healthy worker effect, being rather stronger in observations with a latency of <10 years than in observations beyond 10 years latency. This healthy worker effect is seen even more clearly in the results for circulatory disease and respiratory disease (Tables 3 and 4).
10 428 OCCUPATIONAL MEDICINE Overall cancer registration experience Since cancer registration gives a more complete picture of cancer incidence than cancer mortality, the rest of this discussion will concentrate on the Carstairs adjusted cancer registration data. For men and women, the total number of cancers was close to the expected number. For two of the four cancers of public concern (leukaemia and uterine), and for five of the eight cancer groups examined because a relevant carcinogen was known to have been present in the workplace [pleura, skin (excluding melanoma), thyroid, multiple myeloma and leukaemia (excluding chronic lymphatic)], there were no findings of note. Four cancers produced findings worthy of more detailed description, which is set out in the following sections. Female lung cancer The excess of lung cancer in women in the cohort is the most striking finding from this investigation. The 11 cases observed are 2.7 times as many as expected, a statistically significant finding. In contrast to the raised risk in women, there were only two cases in men, around half as many as expected. To the extent that men and women have distinct occupational profiles in the plant, this difference could indicate a risk arising from work largely occupied by women. We know that ~80% of the women work in fabrication areas, which might suggest a source of risk present in these areas. On the other hand, a substantial proportion of men (around half) also work in the fabrication areas, and if this was the source of exposure to a lung carcinogen that generated the excess in the women, one might expect to see at least some sign of an excess in men. We have not assessed the extent to which exposures for males and females in fabrication might differ, since it was beyond the scope of this initial investigation. The female lung cancer excess was higher in those cases with <10 years latency than for a latency of 10 years, the reverse of the pattern normally expected in the presence of an occupational carcinogen. However, the factory has only been in existence since 1970 and the workforce has expanded considerably from the small numbers present in the earlier years, meaning that there is limited potential for observations with a long latency period, particularly in the more recently employed. Furthermore, if a potent carcinogen had been recently introduced into this working environment, an effect could only be evident in short latency observations. It is also worth noting that within the group of women who were first employed before 1982 there are no cases of lung cancer with <10 years latency, and an excess which is just significant for longer latency observations. Other factors complicate the interpretation of these findings. For example, the relatively high age at hire of the lung cancer cases (data not shown) raises the possibility of relevant exposures prior to employment at the facility. We have not collected information on smoking habit, although smoking behaviour in the cohort would have to be substantially higher than the comparison population to account for a relative risk of the size observed [12], particularly given that the adjustment for socio-economic factors will have adjusted for the effects of smoking to some extent. The distribution of cell types for the cases is not unusual, as the distribution varies historically and geographically [13]. The interpretation of the lung cancer findings is therefore complex. After careful consideration, we have concluded that we cannot exclude the possibility of some of the observed excess being related to work at the plant. Female stomach cancer There is an excess of stomach cancer in this cohort. The three cases observed are 4.4 times as many as expected, a finding of borderline statistical significance. All three cases occurred in women aged <50 years and were associated with a latency of between 5 and 10 years. There were no stomach cancer cases in men (0.8 cases were expected). Similar lines of argument based on the contrast between the findings in men and women, and the observation of higher risk at shorter latencies apply to these stomach cancer findings as to the lung cancer findings. Stomach cancer was selected for study at the outset of the investigation because it was of concern to the local worker support group. In this situation where cases have been identified prior to formal investigation, statistical significance will tend to be overstated and findings must be interpreted more cautiously. There remains the possibility that some of this excess may be related to work at the plant. Female breast cancer There is a moderate (34%) excess of breast cancer in the cohort as a whole. The only statistically significant finding in relation to breast cancer is the observation of approximately twice as many cases as expected among women first employed in 1982 or later. Breast cancer was selected for study at the outset of the investigation because of its association with ionizing radiation, but also because it was of concern to the local worker support group. The finding was not statistically significant, and to some extent the reservations about statistical significance as for stomach cancer still apply, although to a lesser extent. Breast cancer risk is strongly modified by hormonal factors and by reproductive history. The influence of such factors on the breast cancer findings in this investigation are unknown. Several recent papers have suggested a role for shiftwork in breast cancer [14 16]. The proposed mechanism is the suppression of melatonin levels produced by exposure to light at night.
11 D. M. MCELVENNY ET AL.: CANCER INCIDENCE, MORTALITY AND SEMICONDUCTOR MANUFACTURING 429 This hypothesis has not been fully evaluated, but has some biological plausibility, and epidemiological support. Since shiftwork is widespread in this workforce, it is possible that this is relevant to the observed excess. More detailed examination of the cases work histories is required before more definite conclusions can be drawn. Brain cancer Brain cancer was not one of the cancer categories selected for study in this investigation, and as such we were not able to calculate SRRs. However, three of the four cases identified were fatal, giving rise to an unadjusted SMR of 401 (95% CI = ). The cases had latencies of 2, 3, 6 and 11 years, and there were no cases among women. In the context of a moderately large number of different end points examined in this investigation, and given the short latencies of three of the four cases, it seems reasonable to see this result as more likely to be due to chance than a consequence of work at the plant, although the possibility of a work-related explanation cannot be entirely ruled out. Occupational factors In the current investigation, only data readily available on the whole population were used. The only exposure indicator available on this basis was a marker identifying individuals who worked in the fabrication areas. The marker did not, of course, give specific information about exposure, but does mark those with potential exposure to the wide range of agents characteristic of semiconductor fabrication. It would also include those with greater potential for exposure to physical agents such as ultraviolet or ionizing radiations. Conversely, the non-fab group would include all the office or electronic laboratory based staff with little or no potential for chemical exposures. It is possible that if misclassification of exposure exists between fab and non-fab workers then this would tend to mask an adverse health effect associated with hazardous exposure. However, only limited conclusions can be drawn from analyses based on this marker. Non-occupational factors As a result of the purposely limited aims of the investigation, no data on other possible risk factors were obtained, e.g. smoking (lung cancer) or diet (stomach cancer). This limits what can be concluded on the present data alone. The Carstairs index based adjustment does not directly adjust for variation in potential confounding factors such as smoking, diet or reproductive history. However, health outcomes correlate strongly with the index, and though the reasons for this are not fully known, established risk factors such as smoking and diet are thought to play an important role in the health of a population. In the original analyses of Carstairs and Morris [6] the disease group with the strongest correlation with the index was that for smoking related diseases. It is therefore reasonable to consider the adjustment as controlling, in some part, for the important socio-economic and lifestyle factors, including smoking. Conclusion These findings, particularly those relating to lung cancer, raise the possibility of a work-related risk of cancer, and more detailed studies will be needed to clarify this. We will continue case ascertainment within this cohort, to review the pattern of cancers over time. We are already planning a nested case control study to follow up the findings in relation to lung, stomach, breast and brain cancer, which will address both work and other relevant factors. The Health & Safety Executive has called for a replication of this study in the rest of the British semiconductor industry. Acknowledgements We thank the management and employees at the semiconductor manufacturing facility, without whom this investigation could not have been completed. We also acknowledge the advice of Raymond Agius, Freda Alexander and Lewis Reay, who acted as an independent scientific steering committee for this study, and would like to thank Roger Black, David Brewster, Charles Gillis, Veronica Harris, David Hole and Diane Stockton, for information and advice on Scottish cancer registration data; Sandra Ferguson, for information on cancer registration and cancer mortality rates in the locality of the semiconductor facility; staff at the National Health Service Central Registers in Edinburgh and Southport; Bernie Good, Jan Harding, Phil Irwin, Valerie Clayton and Andrea Grainger, for administrative support; Suzi Curtis, for her independent audit of study method and its implementation; and other staff at the Health & Safety Executive, too numerous to individually mention, for advice and support. An anonymous reviewer made very helpful comments on the paper. A copy of the full report of this investigation is available from the HSE website at References 1. Sorahan T, Waterhouse JAH, McKiernen MJ, Aston RHR. Cancer incidence and cancer mortality in a cohort of semiconductor workers. Br J Ind Med 1985;42: Sorahan T, Pope DJ, McKiernen MJ. Cancer incidence and cancer mortality in a cohort of semiconductor workers: an update. Br J Ind Med 1992;49: WHO. Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death, 8th revision. Geneva: World Health Organization, 1967.
12 430 OCCUPATIONAL MEDICINE 4. WHO. Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death, 9th revision. Geneva: World Health Organization, WHO. Manual of the International Statistical Classification of Diseases, Injuries and Causes of Death, 10th revision. Geneva: World Health Organization, Carstairs V, Morris R. Deprivation and Health in Scotland. Aberdeen: Aberdeen University Press, Marsh GM, Youk AO, Sefcik ST, Alcorn CW. OCMAP-PLUS v3.09 (Beta v1.0) technical notes, draft, July 6. Pittsburgh, PA: University of Pittsburgh, SPSS. SPSS Base 10.0 User s Guide. Chicago, IL: SPSS Inc., Bailar JC III, Bobak M, Fowler B, et al. Reply to: rebuttal from the Health and Safety Executive. Int J Occup Environ Health 2000;6:262 [letter]. 10. Bailar JC III, Bobak M, Fowler B, et al. Open letter to the Health and Safety Executive. Int J Occup Environ Health 2000;6:71 72 [editorial]. 11. McElvenny DM, Osman J, Hodgson JT, Elliott RC. Rebuttal from the Health and Safety Executive. Int J Occup Environ Health 2000;6: [letter]. 12. Axelson O. Confounding from smoking in occupational epidemiology. Br J Ind Med 1989;46: [editorial]. 13. Modan B. Population distribution of histological types of lung cancer. Epidemiologic aspects in Israel and review of the literature. Israel J Med Sci 1978;14: Davis S, Mirch DK, Stevens RG. Shift work, light at night and risk of breast cancer. J Natl Cancer Inst 2001;93: Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology 2001;12: Schernhammer ES, Laden F, Sperzer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the Nurses Health Study. J Natl Cancer Inst 2001;93:
semiconductor workers
British Journal ofindustrial Medicine 1985;42: 546-550 Cancer incidence and cancer mortality in a cohort of semiconductor workers T SORAHAN,' J A H WATERHOUSE,' M J McKIERNAN,2 AND R H R ASTON2 From the
More informationCancer in the Northern Territory :
Cancer in the Northern Territory 1991 21: Incidence, mortality and survival Xiaohua Zhang John Condon Karen Dempsey Lindy Garling Acknowledgements The authors are grateful to the many people, who have
More informationEnvironmental Health: A Global Access Science Source
Environmental Health: A Global Access Science Source BioMed Central Research Mortality among US employees of a large computer manufacturing company: 1969 2001 Richard W Clapp* Open Access Address: Department
More informationMortality of United Kingdom oil refinery and petroleum distribution workers,
Mortality of United Kingdom oil refinery and petroleum distribution workers, 1951 1998 T. Sorahan, L. Nichols and J. M. Harrington Institute of Occupational Health, University of Birmingham, Edgbaston,
More informationMortality among aircraft manufacturing workers
Occup Environ Med 1999;56:581 597 581 International Epidemiology Institute, 1500 Research Boulevard, Rockville, MD 20850 3127, USA J D Boice J P Fryzek C J Sadler J K McLaughlin IHI Environmental, 640
More informationE thylene oxide is an important chemical intermediate in
358 ORIGINAL ARTICLE Mortality of workers exposed to ethylene oxide: extended follow up of a British cohort D Coggon, E C Harris, J Poole, K T Palmer... See end of article for authors affiliations... Correspondence
More informationferrochromium workers
British Journal of Industrial Medicine 1980;37:121-127 Mortality and incidence of tumours among ferrochromium workers G AXELSSON,l R RYLANDER,l AND A SCHMIDT2 From the Department of Environmental Hygiene,'
More informationTrends in Cancer Survival in Scotland
Scottish Cancer Intelligence Unit Trends in Cancer Survival in Scotland - Trends in survival are presented for the half million adult cancer patients diagnosed in Scotland between and. The Results show,
More informationEPIDEMIOLOGICAL STUDY
IP THE INSTITUTE OF PETROLEUM EPIDEMIOLOGICAL STUDY EXECUTIVE SUMMARIES IP THE INSTITUTE OF PETROLEUM 61 NEW CAVENDISH STREET, LONDON, W1M 8AR SWITCHBOARD : 0171-467 7100 FAX : DIRECT LINE 0171-255 1472
More informationKeppel Street, London WC1E 7HT. In addition, a large proportion of melanomas. been suggested that prolonged exposure to
Br. J. Cancer (1981) 44, 886 THE RELATIONSHIP OF MALIGNANT MELANOMA, BASAL AND SQUAMOUS SKIN CANCERS TO INDOOR AND OUTDOOR WORK V. BERAL AND N. ROBINSON From the Epidemiological Monitoring Unit, London
More informationCancer mortality and saccharin consumption
Brit. J. prev. soc. Med. (1976), 30, 151-157 Cancer mortality and saccharin consumption in diabetics BRUCE ARMSTRONG*1 A. J. LEA,t A. M. ADELSTEIN2, J. W. DONOVANt2, G. C. WHITE2, S. RUTTLE3 Department
More informationDavid McLean Centre for Public Health Research Massey University. Historical Cohort Studies of Occupational Cancer in New Zealand
David McLean Centre for Public Health Research Massey University Historical Cohort Studies of Occupational Cancer in New Zealand Historical Cohort Study Design Disease Source population Exposed Non-exposed
More informationA review of the impact of shift work on occupational cancer
A review of the impact of shift work on occupational cancer www.iosh.co.uk/shiftworkreview Research review Our research and development programme IOSH, the Chartered body for safety and health professionals,
More informationJournal of the Statistical and Social Inquiry Society of Ireland Volume XXXIX. D.W. Donnelly & A.T. Gavin
Journal of the Statistical and Social Inquiry Society of Ireland Volume XXXIX TRENDS AND PATTERNS IN CANCER MORTALITY IN NORTHERN IRELAND D.W. Donnelly & A.T. Gavin NI Cancer Registry, Queen s University
More informationInformation Services Division NHS National Services Scotland
Cancer in Scotland April 2017 First published in June 2004, revised with each National Statistics publication Next due for revision October 2017 Information Services Division NHS National Services Scotland
More informationAPPENDIX ONE: ICD CODES
APPENDIX ONE: ICD CODES ICD-10-AM ICD-9-CM Malignant neoplasms C00 C97 140 208, 238.6, 273.3 Lip, oral cavity and pharynx C00 C14 140 149 Digestive organs C15 C26 150 157, 159 Oesophagus 4 C15 150 excluding
More informationHazelinks - Cancer incidence analysis (First data extraction)
Hazelinks - Cancer incidence analysis (First data extraction) Authors Prof Malcolm Sim Ms Christina Dimitriadis Dr Caroline Gao Mr Anthony Del Monaco 1 1 Contents Abbreviations... 3 Executive Summary...
More informationDownloaded from:
Hodgson, JT; McElvenny, DM; Darnton, AJ; Price, MJ; Peto, J (25) The expected burden of mesothelioma mortality in Great Britain from 22 to 25. British journal of cancer, 92 (3). pp. 587-93. ISSN 7-92 DOI:
More informationBrief Update on Cancer Occurrence in East Metro Communities
Brief Update on Cancer Occurrence in East Metro Communities FEBRUARY, 2018 Brief Update on Cancer Occurrence in East Metro Communities Minnesota Department of Health Minnesota Cancer Reporting System PO
More informationTrends in Cancer Survival in NSW 1980 to 1996
Trends in Cancer Survival in NSW 19 to 1996 Xue Q Yu Dianne O Connell Bruce Armstrong Robert Gibberd Cancer Epidemiology Research Unit Cancer Research and Registers Division The Cancer Council NSW August
More informationCancer in Ireland : Annual Report of the National Cancer Registry
Cancer in Ireland 1994-213: Annual Report of the National Cancer Registry 215 Page 3 ABBREVIATIONS 95% CI 95% confidence interval APC Annual percentage change ASR Age-standardised rate (European standard
More informationCANCER INCIDENCE NEAR THE BROOKHAVEN LANDFILL
CANCER INCIDENCE NEAR THE BROOKHAVEN LANDFILL CENSUS TRACTS 1591.03, 1591.06, 1592.03, 1592.04 AND 1593.00 TOWN OF BROOKHAVEN, SUFFOLK COUNTY, NEW YORK, 1983-1992 WITH UPDATED INFORMATION ON CANCER INCIDENCE
More informationCancer in Estonia 2014
Cancer in Estonia 2014 Estonian Cancer Registry (ECR) is a population-based registry that collects data on all cancer cases in Estonia. More information about ECR is available at the webpage of National
More informationAge-standardised rate ratios (SRR) and rate differences (SRD) of endometrial cancer, for Māori, Pacific and Asian compared to European/Other
Figure 22: Standardised rates of endometrial cancer for 25+ year-olds, by ethnicity Table 25: Age-standardised rate ratios (SRR) and rate differences (SRD) of endometrial cancer, for Māori, Pacific and
More informationCANCER IN NSW ABORIGINAL PEOPLES. Incidence, mortality and survival September 2012
CANCER IN NSW ABORIGINAL PEOPLES Incidence, mortality and survival September 2012 CANCER IN NSW ABORIGINAL PEOPLES Contents Tables 1 Figures 2 Message from the Chief Cancer Officer 4 Executive summary
More informationALL CANCER (EXCLUDING NMSC)
ALL CANCER (EXCLUDING NMSC) AVERAGE NUMBER OF CASES PER YEAR (2012-2016) AVERAGE NUMBER OF DEATHS PER YEAR (2012-2016) Male Female Both sexes Male Female Both sexes 4,607 4,632 9,240 1 2,238 2,036 4,274
More informationChapter 2 Geographical patterns in cancer in the UK and Ireland
Chapter 2 Geographical patterns in cancer in the UK and Ireland Mike Quinn, Helen Wood, Steve Rowan, Nicola Cooper Summary Incidence and mortality for cancers strongly related to smoking and alcohol (larynx;
More informationMortality of female gas mask assemblers
British Journal of Industrial Medicine 1982;39:34-38 Mortality of female gas mask assemblers B K WIGNALL' AND A J FOX2 From the Department of Radiology,' St George's Hospital, and Departmenit of Mathematics,2
More informationT his report presents the results of a second update of a historical
248 ORIGINAL ARTICLE Updated epidemiological study of workers at two California petroleum refineries, 1950 95 K P Satin, W J Bailey, K L Newton, A Y Ross, O Wong... See end of article for authors affiliations...
More informationRESEARCH COMMUNICATION. Searching for Cancer Deaths in Australia: National Death Index vs. Cancer Registries
RESEARCH COMMUNICATION Searching for Cancer Deaths in Australia: National Death Index vs. Cancer Registries Christina M Nagle 1 *, David M Purdie 2, Penelope M Webb 2, Adèle C Green 2, Christopher J Bain
More informationHaematological malignancies in England Cancers Diagnosed Haematological malignancies in England Cancers Diagnosed
Northern and Yorkshire Cancer Registry and Information Service Haematological malignancies in England Cancers Diagnosed 2001-2008 Haematological 2001-2008 Malignancies www.nycris.nhs.uk www.nycris.nhs.uk
More informationNational Cancer Intelligence Network Routes to Diagnosis:Investigation of melanoma unknowns
National Cancer Intelligence Network Routes to Diagnosis:Investigation of melanoma unknowns Routes to Diagnosis: Investigation of melanoma unknowns About Public Health England Public Health England exists
More informationThe Burden of Work-related Cancer in Great Britain
The Burden of Work-related Cancer in Great Britain L Rushton 1, T. Brown 2, R Bevan 3, J Cherrie 4, L Fortunato 1, S Bagga 3, P Holmes 3, S Hutchings 1, R Slack 3, M Van Tongeren 4, C Young 2 1 Dept. of
More informationALL CANCER (EXCLUDING NMSC)
ALL CANCER (EXCLUDING NMSC) AVERAGE NUMBER OF CASES PER YEAR (2011-2015) AVERAGE NUMBER OF DEATHS PER YEAR (2011-2015) Male Female Both sexes Male Female Both sexes 4,557 4,516 9,073 1 2,196 1,984 4,180
More informationANNUAL CANCER REGISTRY REPORT-2005
ANNUAL CANCER REGISTRY REPORT-25 CANCER STATISTICS Distribution of neoplasms Of a total of 3,115 new neoplasms diagnosed or treated at the Hospital from January 25 to December, 25, 1,473 were seen in males
More informationTARGETS To reduce the age-standardised mortality rate from cervical cancer in all New Zealand women to 3.5 per or less by the year 2005.
Cervical Cancer Key points Annually, around 85 women die from, and 230 women are registered with, cervical cancer. The decline in both incidence and mortality rates for cervical cancer has accelerated
More information2. Studies of Cancer in Humans
94 IARC MONOGRAPHS VOLUME 88 2.1 Cohort studies 2. Studies of Cancer in Humans More than 25 cohort studies have examined the association between formaldehyde and cancer. Since the previous IARC monograph
More informationDread Disease Insurance towards local experience
Dread Disease Insurance towards local experience Wolfgang Droste IAAHS - Colloquium 2004 29 April 2004 A Berkshire Hathaway Company A Berkshire Hathaway Company? Contents 1. Gen Re s Survey 2. International
More informationInformation Services Division NHS National Services Scotland
Cancer in Scotland April 2013 First published in June 2004, revised with each National Statistics publication Next due for revision October 2013 Information Services Division NHS National Services Scotland
More informationDownloaded from:
Rachet, B; Coleman, MP; Ellis, L; Shah, A; Cooper, N; Rasulo, D; Westlake, S (8) Cancer survival in the Primary Care Trusts of England, 1998-4. Technical Report. Office for National Statistics. Downloaded
More informationIARC Monographs on the Evaluation of Carcinogenic Risks to Humans IARC Monograph Evaluations
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans IARC Monograph Evaluations Subgroup work humans Sufficient evidence Limited evidence Inadequate evidence Evidence suggesting lack of carcinogenicity
More informationOrgan site (ICD code) Exposure categories cases/ deaths. Men Tire material handling
categories Chen et al (997), PR China 788 workers (5 men, 2798 women) employed > year in 3 factories, through 972 Work history and payroll data from Tire material handling SIR 2. (p
More informationCancer incidence near municipal solid waste incinerators in Great Britain. COC statement COC/00/S1 - March 2000
Cancer incidence near municipal solid waste incinerators in Great Britain COC statement COC/00/S1 - March 2000 Introduction 1. There have been very few epidemiological studies published which investigated
More informationCancer in Ireland with estimates for
Cancer in Ireland 1994-2015 with estimates for 2015-2017: Annual Report of the National Cancer Registry 2017 Page ABBREVIATIONS 95% CI 95% confidence interval APC Annual percentage change ASR Age-standardised
More informationAn industry wide mortality study of chemical workers occupationally exposed to benzene.
British Journal of Industrial Medicine 1987;44:382-395 An industry wide mortality study of chemical workers occupationally exposed to benzene. II Dose response analyses O WONG From Environmental Health
More informationMORTALITY FROM LUNG CANCER IN ASBESTOS WORKERS
Brit. J. industr. Med., 1955,12, 81. MORTALITY FROM LUNG CANCER IN ASBESTOS WORKERS BY RICHARD DOLL From the Statistical Research UInit, Medical Research Council, Lonldon (RECEIVED FOR PUBLICATION AUGUST
More informationBreast and Colorectal Cancer mortality. in Scotland can we do better?
Risk of skin cancer following phototherapy for neonatal jaundice: retrospective cohort study Breast and Colorectal Cancer mortality David H Brewster, 1,2 Janet S Tucker, 3,4 Michael Fleming, 1 Carole Morris,
More informationCORONARY HIEART DISEASE IN TRANSPORT WORKERS A PROGRESS REPORT* BY J. N. MORRIS and P. A. B. RAFFLE
Brit. J. industr. Med., 1954, 11, 260. CORONARY HIEART DISEASE IN TRANSPORT WORKERS A PROGRESS REPORT* BY J. N. MORRIS and P. A. B. RAFFLE From the Social Medicine Research Unit, Medical Research Council,
More informationNested case-control study of leukaemia, multiple myeloma, and kidney cancer in a cohort of petroleum workers exposed to gasoline
Occup Environ Med 1999;56:217 221 217 Applied Health Sciences, San Mateo, California, USA O Wong L Trent F Harris Tulane University Medical Center, New Orleans, Louisiana, USA O Wong University of California,
More informationEpidemiological survey of maintenance workers in
British Journal of Industrial Medicine 1983 ;40:340-345 Epidemiological survey of maintenance workers in London Transport Executive bus garages and Chiswick Works L RUSHTON, M R ALDERSON, AND C R NAGARAJAH
More informationNational Cancer Intelligence Network Trends in incidence and outcome for haematological cancers in England:
National Cancer Intelligence Network Trends in incidence and outcome for haematological cancers in England: 2001-2010 Trends in incidence and outcome for haematological cancers in England: 2001-2010 About
More informationCover Page. The handle holds various files of this Leiden University dissertation.
Cover Page The handle http://hdl.handle.net/188/20915 holds various files of this Leiden University dissertation. Author: Flinterman, Linda Elisabeth Title: Risk factors for a first and recurrent venous
More informationSurvival in Teenagers and Young. Adults with Cancer in the UK
Survival in Teenagers and Young Adults with Cancer in the UK Survival in Teenagers and Young Adults (TYA) with Cancer in the UK A comparative report comparing TYA cancer survival with that of children
More informationPlease note that the Coding Advisory Service Telephone Number is The number is manned Tuesday to Thursday from to hrs.
CODING GUIDELINES No. 12 September, 2002 Please note that the Coding Advisory Service Telephone Number is 0131-552-7325. The number is manned Tuesday to Thursday from 09.00 to 17.00 hrs. CODING GUIDELINES
More informationCancer in Ireland : Annual Report of the National Cancer Registry
Cancer in Ireland 1-: Annual Report of the National Cancer Registry ABBREVIATIONS % CI % confidence interval APC Annual percentage change ASR Age-standardised rate (European standard population) CNS Central
More informationExtract from Cancer survival in Europe by country and age: results of EUROCARE-5 a population-based study
EUROCARE-5 on-line database Data and methods Extract from Cancer survival in Europe 1999 2007 by country and age: results of EUROCARE-5 a population-based study De Angelis R, Sant M, Coleman MP, Francisci
More informationAsbestos-related diseases in Great Britain, 2018
Health and Safety Executive Data up to December 2017 Annual Statistics Published 31 st October 2018 Asbestos-related diseases in Great Britain, 2018 Contents Summary 2 Introduction 3 Asbestos-related cancers
More informationEliminating occupational cancer
Eliminating occupational cancer John Cherrie IOSH National Safety Symposium 2014 INSTITUTE OF OCCUPATIONAL MEDICINE. Edinburgh. UK www.iom-world.org Summary Workplace cancer has been a problem for some
More informationLung Cancer and Mesothelioma Site Specific Clinical Reference Group Data Quality Report 2009
Lung Cancer and Mesothelioma Site Specific Clinical Reference Group Data Quality Report 9 Sharma P Riaz Karen M Linklater Henrik Møller Margreet Lüchtenborg Contents 1. Introduction... 1 2. Methods...
More informationSMOKING, HEALTH AND SOCIAL CARE (SCOTLAND) ACT Implications for Voluntary Sector Social Care Service Providers
SMOKING, HEALTH AND SOCIAL CARE (SCOTLAND) ACT 2005 Implications for Voluntary Sector Social Care Service Providers Legal requirements The Smoking, Health and Social Care (Scotland) Act 2005 came into
More informationAviva Group Protection Our guide to cancer
ww For employers use only. Aviva Group Protection Our guide to cancer 1 2 In 2013, 131 million working days were lost due to sickness absence in the UK, at an average of 4.4 working days per employee 1.
More informationTable 2.3. Nested case-control studies of arsenic exposure and cancer
Lee- Feldstein (1989) Montana, 1925-1947 Respiratory cancer (160-164) 302 employees who died of respiratory cancer during the follow up of a Montana cohort of 8045 white male employees employed at least
More informationUpper aerodigestive cancer in battery manufacturers and steel workers exposed to
Occupational and Environmental Medicine 1996;53:445-449 MRC Environmental Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton D Coggon B Pannett G Wield Correspondence
More informationFurther follow up of mortality in a United Kingdom
British Journal of Industnial Medicine 1993;50:561-569 Further follow up of mortality in a United Kingdom oil distribution centre cohort Lesley Rushton Abstract Results- of an extension of follow up (1976
More informationInformation Services Division NHS National Services Scotland
Cancer in Scotland October 2012 First published in June 2004, revised with each National Statistics publication Next due for revision April 2013 Information Services Division NHS National Services Scotland
More informationNational Cancer Patient Experience Survey Results. University Hospitals of Leicester NHS Trust. Published July 2016
National Cancer Patient Experience Survey 2015 Results University Hospitals of Leicester NHS Trust Published July 2016 Revised 17th August 2016 The National Cancer Patient Experience Survey is undertaken
More informationTable 2.9. Cohort studies of exposure to benzene and the risk for non-hodgkin lymphoma (NHL)
Wong (1987) men chemical workers from 7 plants occupationally exposed to benzene for at least mo 197 1975, and 7 workers from the same plants not exposed to benzene Jobs with exposure to benzene classified
More informationNational Cancer Patient Experience Survey Results. East Kent Hospitals University NHS Foundation Trust. Published July 2016
National Cancer Patient Experience Survey 2015 Results East Kent Hospitals University NHS Foundation Trust Published July 2016 Revised 17th August 2016 The National Cancer Patient Experience Survey is
More informationNational Cancer Patient Experience Survey Results. Milton Keynes University Hospital NHS Foundation Trust. Published July 2016
National Cancer Patient Experience Survey 2015 Results Milton Keynes University Hospital NHS Foundation Trust Published July 2016 The National Cancer Patient Experience Survey is undertaken by Quality
More informationDental Earnings and Expenses: Scotland, 2011/12
Dental Earnings and Expenses: Published 25 October 2013 We are the trusted source of authoritative data and information relating to health and care. www.hscic.gov.uk enquiries@hscic.gov.uk Author: Responsible
More informationpetroleum refinery workers
British Journal of Industrial Medicine 1992;49:203-212 An updated cause specific mortality study of petroleum refinery workers T G Dagg, K P Satin, W J Bailey, 0 Wong, L L Harmon, R E Swencicki Abstract
More informationSANTA SUSANA FIELD LABORATORY EPIDEMIOLOGICAL STUDY: REPORT OF THE OVERSIGHT PANEL SEPTEMBER 1997
SANTA SUSANA FIELD LABORATORY EPIDEMIOLOGICAL STUDY: REPORT OF THE OVERSIGHT PANEL SEPTEMBER 1997 Daniel Hirsch, Co-Chair * OVERSIGHT PANEL MEMBERS Committee to Bridge the Gap, Los Angeles, California
More informationGSK Medicine: Study No.: Title: Rationale: Objectives: Indication: Study Investigators/Centers: Research Methods:
The study listed may include approved and non-approved uses, formulations or treatment regimens. The results reported in any single study may not reflect the overall results obtained on studies of a product.
More informationSICKNESS ABSENCE BEFORE THE FIRST CLINICAL
Brit. J. industr. Med., 1954, 11, 20. SICKNESS ABSENCE BEFORE THE FIRST CLINICAL EPISODE OF CORONARY HEART DISEASE BY J. A. HEADY, J. N. MORRIS, F. J. LLOYD, and P. A. B. RAFFLE From the Social Medicine
More informationOccupational Health Issues and Social Security
Occupational Health Issues and Social Security October 27, 2012 Seong-Kyu Kang Director General, Seoul Regional Office KOSHA (Korea Occupational Safety and Health Agency) 2012-10-27 Collegium Ramazzini
More informationMacmillan-NICR Partnership: GP Federation Cancer Profiles (with Prevalence )
Macmillan-NICR Partnership: GP Federation Cancer Profiles 2011-2015 (with Prevalence 1993-2015) 1 C a n c e r S t a t i s t i c s b y G P F e d e r a t i o n a r e a : 2 0 1 1-2015 Table of Contents Introduction...
More informationCosting report: Lipid modification Implementing the NICE guideline on lipid modification (CG181)
Putting NICE guidance into practice Costing report: Lipid modification Implementing the NICE guideline on lipid modification (CG181) Published: July 2014 This costing report accompanies Lipid modification:
More informationWinnebago County, Illinois. Review of Winnebago County Cancer Mortality and Incidence ( )
Winnebago County, Illinois Review of Winnebago County Cancer Mortality and Incidence (1988 2008) August 2011 Review of Winnebago County Cancer Mortality and Incidence August 2011 Background: Cancer is
More informationCancer survival and prevalence in Tasmania
Cancer survival and prevalence in Tasmania 1978-2008 Cancer survival and prevalence in Tasmania 1978-2008 Tasmanian Cancer Registry University of Tasmania Menzies Research Institute Tasmania 17 Liverpool
More informationComments DRAFT Preamble to the IARC Monograph. Health and Safety Department International Union, UAW 8000 East Jefferson Avenue Detroit, MI 48214
Comments DRAFT Preamble to the IARC Monograph Health and Safety Department International Union, UAW 8000 East Jefferson Avenue Detroit, MI 48214 The International Union, UAW affirms the importance of the
More informationUnderstanding lymphoma: the importance of patient data
Understanding lymphoma: the importance of patient data Introduction what is a cancer registry and why is it important? Cancer registries collect detailed, personalised information and data about cancer
More informationSpecial guidelines for preparation and quality approval of reviews in the form of reference documents in the field of occupational diseases
Special guidelines for preparation and quality approval of reviews in the form of reference documents in the field of occupational diseases November 2010 (1 st July 2016: The National Board of Industrial
More informationCancer in Utah: An Overview of Cancer Incidence and Mortality from
Cancer in Utah: An Overview of Cancer Incidence and Mortality from 1973-2010 A publication of the Utah Cancer Registry January 2014 Prepared by: C. Janna Harrell, MS Senior Research Analyst Kimberly A.
More informationGeneral practice. Abstract. Subjects and methods. Introduction. examining the effect of use of oral contraceptives on mortality in the long term.
Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners oral contraception study Valerie Beral, Carol Hermon, Clifford
More informationPresumptive Diseases and Workers Compensation Laws
Presumptive Diseases and Workers Compensation Laws Presented by: THE LAW OFFICE OF RICKY D. GREEN, PLLC 9600 Escarpment Blvd, Suite 745-52 Austin, Texas 78749 (512) 280-0055 Phone (866) 853-9407 Toll Free
More informationEstimated Minnesota Cancer Prevalence, January 1, MCSS Epidemiology Report 04:2. April 2004
MCSS Epidemiology Report 04:2 Suggested citation Perkins C, Bushhouse S.. Minnesota Cancer Surveillance System. Minneapolis, MN, http://www.health.state.mn.us/divs/hpcd/ cdee/mcss),. 1 Background Cancer
More informationPrinciples of publishing
Principles of publishing Issues of authorship, duplicate publication and plagiarism in scientific journal papers can cause considerable conflict among members of research teams and embarrassment for both
More informationAudit Report. National Audit of Paediatric Radiology Services in Hospitals
Audit Report National Audit of Paediatric Radiology Services in Hospitals www.rcr.ac.uk 2 Contents Introduction 3 Standards 4 Material and methods 5 Results 6 Discussion 8 References 10 www.rcr.ac.uk 3
More informationCancer mortality in the British rubber industry:
British Journal of Industrial Medicine 1986;43:363-373 Cancer mortality in the British rubber industry: 1946-80 T SORAHAN,1 H G PARKES,2 C A VEYS,2 AND J A H WATERHOUSE' From the Cancer Epidemiology Research
More informationCANCER IN TASMANIA INCIDENCE AND MORTALITY 1996
CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 CANCER IN TASMANIA INCIDENCE AND MORTALITY 1996 Menzies Centre For Population Health Research Editors: Dace Shugg, Terence Dwyer and Leigh Blizzard Publication
More informationabcdefghijklmnopqrstu
Chief Medical Officer Directorate Chief Medical Officer and Secretariat Division abcdefghijklmnopqrstu T: 0131-244 2399 F: 0131-244 2989 E: sandra.falconer@scotland.gsi.gov.uk NHS Board Medical and Nursing
More informationPre-Online Release of Results from International Study of Hardmetal Production Workers
Pre-Online Release of Results from International Study of Hardmetal Production Workers ** IMPORTANT NOTICE ** This paper was peer-reviewed and accepted for publication by the Journal of Occupational and
More informationCause of Death Mortality: International Trends by Socio-Economic Group
Cause of Death Mortality: International Trends by Socio-Economic Group Andrew J.G. Cairns Heriot-Watt University Edinburgh Director Actuarial Research Centre IFoA Joint work with C. Redondo D. Blake K.
More informationCancer Data Review ( ) Selected Zip Codes of Warminster, Warrington, and Horsham, PA
Agency for Toxic Substances and Disease Registry Division of Community Health Investigations Summary Key Messages This cancer data review provides an inconclusive picture of cancer incidence rates in Horsham,
More informationMeasles, Mumps, Rubella (MMR) Vaccine discussion pack. an information guide for health professionals and parents
Measles, Mumps, Rubella (MMR) Vaccine discussion pack an information guide for health professionals and parents The MMR discussion pack an information guide for health professionals and parents Published
More informationValidation of death certificates in asbestos workers
Brit. J. industr. Med., 1969, 26, 302-307 Validation of death certificates in asbestos workers M. L. NEWHOUSE AND J. C. WAGNER London School of Hygiene and Tropical Medicine TUC Centenary Institute of
More informationTable E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths
RSNA, 2016 10.1148/radiol.2016152472 Table E1. Standardized Mortality Ratios for Total and Specific Causes of Death Parameter Radiologists Psychiatrists No. of Deaths Observed/Expected No. of Deaths Observed/Expected
More informationWLH Tumor Frequencies between cohort enrollment and 31-Dec Below the Women Lifestyle and Health tumor frequencies are tabulated according to:
WLH Tumor Frequencies between cohort enrollment and 31-Dec 2012 DESCRIPTION Below the Women Lifestyle and Health tumor frequencies are tabulated according to: Benign =171 (Cervix uteri) treated as not
More informationNUTRITION SCREENING SURVEYS IN CARE HOMES IN ENGLAND
NUTRITION SCREENING SURVEYS IN CARE HOMES IN ENGLAND A report based on the amalgamated data from the four Nutrition Screening Week surveys undertaken by BAPEN in 2007, 2008, 2010 and 2011 C A Russell and
More information2. Morbidity. Incidence
2. Morbidity This chapter reports on country-level estimates of incidence, case fatality and prevalence of the following conditions: myocardial infarction (heart attack), stroke, angina and heart failure.
More information